Acousti-Celotex Acoustic Ceiling Tile (Celotex Corporation)

Acousti-Celotex was a mineral fiberboard acoustic ceiling tile manufactured by the Celotex Corporation and sold widely across the United States from approximately 1945 through 1972. Installed in schools, offices, hospitals, and residential buildings throughout the postwar construction boom, the product contained chrysotile asbestos as a functional component of its mineral fiberboard matrix. Workers who cut, nailed, or removed these tiles—and those who later renovated or demolished buildings where the tiles had been installed—faced measurable asbestos exposure. The Celotex Corporation Asbestos Settlement Trust was established to compensate individuals harmed by Celotex asbestos-containing products, including Acousti-Celotex.

Product Description

Acousti-Celotex was part of Celotex Corporation’s broader line of building materials that dominated the mid-century commercial and institutional construction market. The tile was designed to reduce sound transmission in interior spaces, a feature that became standard in postwar office construction and school building programs funded under state and federal initiatives. Marketed as an economical and effective acoustic solution, Acousti-Celotex tiles were sold to general contractors, specialty subcontractors, and building supply distributors throughout the continental United States.

The product was typically manufactured as rigid flat panels intended for suspension in grid systems or direct adhesion and mechanical fastening to ceiling substrates. Celotex Corporation produced the tiles at manufacturing facilities whose processes incorporated raw asbestos fiber into the mineral fiberboard base material. The tiles were marketed under the Acousti-Celotex name during the period spanning roughly 1945 to 1972, after which evolving regulatory awareness and material substitution practices gradually displaced asbestos-containing formulations.

Celotex Corporation itself was a major diversified building products manufacturer. Following years of asbestos-related litigation stemming from multiple product lines, the company’s asbestos liabilities were resolved through the establishment of a dedicated bankruptcy trust, the Celotex Corporation Asbestos Settlement Trust, which remains an active claims-paying entity.

Asbestos Content

Acousti-Celotex ceiling tiles contained chrysotile asbestos integrated into a mineral fiberboard matrix. Chrysotile, also known as white asbestos, is the most widely used form of asbestos in commercial building products and is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC) and regulated as a hazardous material under OSHA’s asbestos standards (29 CFR 1910.1001 and 29 CFR 1926.1101) and the EPA’s Asbestos Hazard Emergency Response Act (AHERA).

In acoustic ceiling tiles of this era, asbestos fiber served multiple functional roles. It contributed tensile strength and dimensional stability to the mineral fiberboard substrate, improved the tile’s resistance to fire and heat, and helped bind the matrix of mineral and fibrous components that gave the product its sound-dampening properties. The asbestos was not coated or encapsulated in any manner that would prevent fiber release during mechanical disturbance; it was integrated throughout the body of the tile material itself.

Under AHERA, acoustic ceiling tile is specifically identified as a suspect asbestos-containing material (ACM) in school buildings, and inspection protocols require sampling and laboratory analysis before any renovation or demolition activity. Buildings constructed or renovated between the 1940s and early 1970s that used Acousti-Celotex or comparable mineral fiberboard ceiling products may contain regulated quantities of asbestos.

How Workers Were Exposed

Workers across multiple trades encountered Acousti-Celotex tiles in ways that generated airborne asbestos fibers. Exposure occurred primarily during installation, modification, and removal of the tiles, and risk was compounded by the fact that asbestos fiber hazards were not disclosed to workers during much of the product’s active production period.

Acoustical ceiling installers worked directly and repeatedly with Acousti-Celotex tiles throughout installation projects. Fitting tiles to grid systems or to irregular ceiling dimensions required cutting the panels with hand saws, utility knives, or mechanical cutting tools. Each cut released asbestos-containing dust into the breathing zone of the installer. Scoring and snapping tiles—a common field technique—also fractured the mineral fiberboard matrix and released fiber. In enclosed interior spaces with limited ventilation, fiber concentrations could accumulate to significant levels. Installers working on large commercial or institutional projects performed these tasks repeatedly across the full duration of a project.

Carpenters encountered Acousti-Celotex tiles when framing ceiling structures, fitting trim, or modifying existing ceiling assemblies. Drilling through tiles to accommodate fixtures, pipes, or conduit created localized dust generation. Carpenters also performed repair and patch work that required cutting replacement tiles to fit damaged sections, exposing them to the same fiber-releasing conditions as original installers.

Building renovation workers represent a particularly significant exposure category. When buildings containing installed Acousti-Celotex tiles underwent renovation, remodeling, or demolition work, previously undisturbed tiles were broken, pried from substrates, or bulk-removed. Tile removal—whether done by hand or with mechanical equipment—consistently released asbestos fibers. Workers who performed these tasks after the tiles had aged may have encountered friable material that released fiber more readily than newly manufactured product. Renovation workers frequently operated without respiratory protection during periods when asbestos hazard awareness and protective requirements were not yet fully implemented or enforced.

Secondary exposure also occurred among bystanders and co-workers present in areas where cutting or removal was underway, including general laborers, other tradespeople, and supervisory personnel sharing workspace on active job sites.

The Celotex Corporation Asbestos Settlement Trust was established following Celotex Corporation’s resolution of asbestos-related liabilities through bankruptcy proceedings. The trust is an active claims-paying entity authorized to compensate individuals diagnosed with asbestos-related diseases who can establish qualifying exposure to Celotex asbestos-containing products, including Acousti-Celotex ceiling tiles.

Eligible claimants include workers who handled, installed, cut, or removed Acousti-Celotex tiles, as well as individuals with documented secondary or bystander exposure in worksites where the product was used. Surviving family members may file claims on behalf of deceased individuals in accordance with trust procedures.

Disease categories typically recognized for trust claims include:

  • Mesothelioma (malignant, pleural or peritoneal)
  • Lung cancer with documented asbestos exposure history
  • Asbestosis and other nonmalignant asbestos-related pulmonary conditions
  • Other asbestos-related cancers as defined in trust distribution procedures

Filing requirements generally include medical documentation of diagnosis, occupational history demonstrating qualifying exposure to Celotex products, and evidence linking the claimant’s work history to Acousti-Celotex or other covered Celotex product lines. Trade records, employment histories, co-worker affidavits, and contractor documentation can all serve as supporting exposure evidence.

Individuals who believe they were exposed to Acousti-Celotex tiles should consult a qualified asbestos attorney to evaluate trust claim eligibility, applicable statutes of limitations in their state, and whether additional product exposures from other manufacturers may support parallel claims against other active asbestos trusts or through direct litigation.